Clinical trial synchronization: Value creation through real-world data
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
An interview with Kristijan Kahler, executive director of innovation evidence at Novartis While...
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically, w...